Local
SELLAS Life Sciences Announces Closing of Underwritten Public Offering and Full Exercise of the ...
A Roundtable is a way to meet new people and discuss this article in person at a local coffee shop or other venue.
Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.
Source: Barre Montpelier Times Argus

NEW YORK, Nov. 20, 2026 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced…
This excerpt comes from the named source. Read the original for the full reporting.
Read the original at Barre Montpelier Times Argus



